\
&
Contact us
\
&
Contact us
This was 4 years ago
Locationonline
ProgrammesGetting ready for the opening of the calls for 2022 also implies finding (potential) partners. To facilitate this, you can participate in a brokerage event with pre-arranged online face-to-face meetings.
Detailed information and registration is on the brokerage website. The agenda is as simple and effective as possible: two full days (from 08:00 until 18:00) with available timeslots for bilateral meetings. The Brokerage Event registration will remain open for the upcoming three months, in order to support long-term networking opportunities. Want to read up on how such a brokerage works? Check this page.
This brokerage event complements the official and EC-organised Cluster 4 Info Day.
This event is open to representatives of companies, universities and research institutes interested in sharing new project ideas and finding collaboration partners.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
